共 50 条
- [31] Efficacy and safety of ustekinumab through Week 16 in patients with moderate-to-severe ulcerative colitis randomised to ustekinumab: results from the UNIFI induction trialJOURNAL OF CROHNS & COLITIS, 2019, 13 : S61 - S62Danese, S.Sands, B. E.O'Brien, C. D.Zhang, H.Johanns, J.Sloan, S.Izanec, J.Szapary, P.Marano, C.Leong, R. W.Rowbotham, D.Targan, S. R.Van Assche, G.
- [32] Association Between Efficacy and Long-Term Outcomes: Four Year Results From the UNIFI Study of Ustekinumab in Ulcerative ColitisAMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S811 - S811Peyrin-Biroulet, LaurentLeong, RupertSands, Bruce E.Miao, YeMarano, ColleenDanese, Silvio
- [33] Efficacy of ustekinumab for Ulcerative Colitis through 4 years: Final clinical and endoscopy outcomes from the UNIFI long-term extensionJOURNAL OF CROHNS & COLITIS, 2023, 17 : I19 - I20Danese, S.Afif, W.Abreu, M.Sandborn, W.Miao, Y.Zhang, H.Panaccione, R.Hisamatsu, T.Scherl, E.Leong, R.Rowbotham, D.Arasaradnam, R.Peyrin-Biroulet, L.Sands, B.Marano, C.
- [34] PREDICTORS OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH NEWLY-DIAGNOSED MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS FROM THE MOSAIK COHORT IN KOREAGASTROENTEROLOGY, 2018, 154 (06) : S814 - S814Lee, Chang KyunPark, Yoo MinHong, Sung NohIm, Jong PilYe, Byong DukCha, Jae MyungJung, Sung-AeLee, Kang-MoonPark, DongilJeen, Yoon TaePark, Young-SookCheon, Jae HeeKim, Hye-SungKim, YoungdoeKim, Hyo-Jong
- [35] Efficacy of ustekinumab for ulcerative colitis through 4 years: Final clinical and endoscopy outcomes from the UNIFI long-term extensionJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 117 - 118Danese, S.Afif, W.Abreu, M. T.Sandborn, W. J.Miao, Y.Zhang, H.Panaccione, R.Hisamatsu, T.Scherl, E. J.Leong, R.Rowbotham, D. S.Arasaradnam, R. P.Peyrin-Biroulet, L.Sands, B. E.Marano, C.
- [36] EFFICACY OF USTEKINUMAB FOR ULCERATIVE COLITIS THROUGH 4 YEARS: FINAL CLINICAL AND ENDOSCOPY OUTCOMES FROM THE UNIFI LONG-TERM EXTENSIONGASTROENTEROLOGY, 2023, 164 (06) : S1094 - S1094Peyrin-Biroulet, LaurentAfif, WaqqasAbreu, Maria T.Danese, SilvioSandborn, William J.Miao, YeZhang, HongyanPanaccione, RemoHisamatsu, TadakazuScherl, Ellen J.Leong, RupertRowbotham, David S.Arasaradnam, Ramesh P.Sands, Bruce E.Marano, Colleen W.
- [37] Sustained improvement in health-related quality of life outcomes in patients with Ulcerative Colitis with long-term tofacitinib treatment in the open-label extension study, OCTAVE OpenJOURNAL OF CROHNS & COLITIS, 2022, 16 : I317 - I319Biedermann, L.Dubinsky, M. C.Vermeire, S.Fellmann, M.Gardiner, S.Hur, P.Mundayat, R.Panes, J.Rubin, D. T.
- [38] MMX® mesalamine treatment for patients with mild-to-moderate ulcerative colitis: improvement in health-related quality of lifeJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A92 - A92Kane, S.Yen, L.Yarlas, A.Karlstadt, R.Solomon, D.Hodgkins, P.
- [39] Health-Related Quality of Life in Patients with Moderate to Severe Ulcerative Colitis: Surgical Intervention versus Immunomodulatory TherapyDIGESTION, 2020, 101 (05) : 631 - 637Portela, FranciscoMinistro, PaulaDe Deus, JoaoCravo, MariliaCotter, JoseDuque, GabrielaFerreira, FredericoRosa, BrunoFerreira, Pedro LopezDias, Claudia CamilaMagro, Fernando
- [40] Ustekinumab Improved Work Productivity in Patients With Moderate to Severe Ulcerative Colitis: Results From the Phase 3 UNIFI Induction and Maintenance StudiesAMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S438 - S438Han, ChenglongNaessens, DominikZhang, HongyanJohanns, JewelMarano, ColleenSands, Bruce E.